ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
11 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
474
|
153K
|
11
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q4 2023 Investor Presentation
|
|
Weazel
|
74 |
31K |
8 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
74
|
31K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Weazel
|
92 |
37K |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
92
|
37K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Weazel
|
92 |
37K |
19 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
92
|
37K
|
19
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
7 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q4 2023 Investor Presentation
|
|
Weazel
|
74 |
31K |
3 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
74
|
31K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Annual Report to Shareholders
|
|
Weazel
|
18 |
5.8K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
18
|
5.8K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
474
|
153K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Annual Report to Shareholders
|
|
Weazel
|
18 |
5.8K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
18
|
5.8K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
474
|
153K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Annual Report to Shareholders
|
|
Weazel
|
18 |
5.8K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
18
|
5.8K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
6
|
|
ASX - By Stock
|
BTH |
Re:
BTH
|
|
Weazel
|
269 |
84K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
269
|
84K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q4 2023 Investor Presentation
|
|
Weazel
|
74 |
31K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
74
|
31K
|
3
|
|
ASX - By Stock
|
WDS |
Re:
Woodside
|
|
Weazel
|
1.1K |
488K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.1K
|
488K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
2x2 Yay Or Nay From The FDA?
|
|
Weazel
|
13 |
4.5K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
13
|
4.5K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Weazel
|
29 |
9.2K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
9.2K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
236 |
85K |
1 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
236
|
85K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
236 |
85K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
236
|
85K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
236 |
85K |
5 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
236
|
85K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Weazel
|
46 |
15K |
12 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
15K
|
12
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
236 |
85K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
236
|
85K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
10 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
236 |
85K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
236
|
85K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Weazel
|
29 |
9.2K |
13 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
29
|
9.2K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Weazel
|
4.2K |
3.7M |
7 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Weazel
|
370 |
131K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
370
|
131K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
474
|
153K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
474
|
153K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Weazel
|
4.2K |
3.7M |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
474
|
153K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Weazel
|
4.2K |
3.7M |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
4
|
|
ASX - By Stock
|
BTH |
Re:
Ann: Half Year FY24 Results Presentation
|
|
Weazel
|
35 |
11K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
35
|
11K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
474
|
153K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
1 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
474
|
153K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
3 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
474
|
153K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
0 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
474
|
153K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
8 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
474
|
153K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.8K |
680K |
11 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
2.8K
|
680K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
474
|
153K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
474 |
153K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
474
|
153K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Weazel
|
370 |
131K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
370
|
131K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Weazel
|
370 |
131K |
10 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
370
|
131K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
Weazel
|
182 |
54K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
182
|
54K
|
4
|
|